SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-078195
Filing Date
2024-03-27
Accepted
2024-03-27 07:04:09
Documents
6
Effectiveness Date
2024-03-27

Document Format Files

Seq Description Document Type Size
1 S-8 d723629ds8.htm S-8 33744
2 EX-5.1 d723629dex51.htm EX-5.1 6992
3 EX-23.2 d723629dex232.htm EX-23.2 1917
4 EX-FILING FEES d723629dexfilingfees.htm EX-FILING FEES 13610
5 GRAPHIC g723629g0323002036143.jpg GRAPHIC 1579
6 GRAPHIC g723629g0323031339013.jpg GRAPHIC 4967
  Complete submission text file 0001193125-24-078195.txt   66722
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278250 | Film No.: 24785746
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)